Christopher Lai

Christopher is the Founding Managing Partner of The March Group (“TMG”) and a seasoned investor and venture builder in emerging food and health technology investments. Christopher is a recognized thought leader in venture capital (Forbes 30 under 30 Asia, Trusted Insight Top 30 Family Office Rising  Stars) and a founding VC member and mentor of the Advanced Venture Capital course at the Hong Kong University of Science and Technology.

Prior to forming TMG with Dr. Harold Schmitz – former Chief Science Officer at Mars. Inc., Stephen Badger – former Chairman and current Board Member at Mars, Inc., and Tony Lau  – former Head of China at Horizons Ventures, Christopher was the Director of  Consumer and Retail Technologies at Horizons Ventures, the private investment arm of Mr. Li Ka Shing, investing across the technology landscape and  managing a portfolio spanning USA, Canada, Israel, France, and China. He is serving or previously served as a member of the Board of Director at Engage3, Digestiva, Agua Brands, Algama, Apollonia Health, Endless West, Bevi, Celsius  (NASDAQ: CELH; as co-Chairman), Perfect Day, and QiFeng. 

A Hong Kong native, Christopher has worked extensively around the world in private investments, corporate finance and M&A at Mooreland Partners/Stifel Financial Corp. NYSE:SF, and biotech corporate and business development at IRX Therapeutics/Brooklyn ImmunoTherapeutics.

Christopher holds B.A. degrees in Neuroscience and Behavior, Genetics, and Economics from Columbia University.